Perspective Therapeutics (CATX) Retained Earnings (2016 - 2025)
Perspective Therapeutics (CATX) has disclosed Retained Earnings for 15 consecutive years, with -$334.8 million as the latest value for Q4 2025.
- Quarterly Retained Earnings fell 44.49% to -$334.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$334.8 million through Dec 2025, down 44.49% year-over-year, with the annual reading at -$334.8 million for FY2025, 44.49% down from the prior year.
- Retained Earnings hit -$334.8 million in Q4 2025 for Perspective Therapeutics, down from $114000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $114000.0 in Q3 2025 to a low of -$334.8 million in Q4 2025.
- Historically, Retained Earnings has averaged -$131.3 million across 5 years, with a median of -$106.1 million in 2022.
- Biggest five-year swings in Retained Earnings: plummeted 54.93% in 2024 and later surged 100.06% in 2025.
- Year by year, Retained Earnings stood at -$95.2 million in 2021, then decreased by 11.31% to -$105.9 million in 2022, then crashed by 43.9% to -$152.4 million in 2023, then crashed by 52.01% to -$231.7 million in 2024, then tumbled by 44.49% to -$334.8 million in 2025.
- Business Quant data shows Retained Earnings for CATX at -$334.8 million in Q4 2025, $114000.0 in Q3 2025, and $3000.0 in Q2 2025.